Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Onconova Therapeutics, Inc. is not a good value stock. Onconova Therapeutics, Inc. is not very popular among insiders. Onconova Therapeutics, Inc. is a mediocre stock to choose.

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the iden...

News

Short Interest in Onconova Therapeutics, Inc. (NASDAQ:ONTX) Drops By 42.9%

Ticker Report Onconova Therapeutics, Inc. (NASDAQ:ONTX Get Free Report) was the recipient of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling...\n more…

Onconova Therapeutics (NASDAQ:ONTX) Receives New Coverage from Analysts at StockNews.com

Zolmax StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a sell rating on...\n more…

Onconova Therapeutics (NASDAQ:ONTX) and FutureWorld (OTCMKTS:FWDG) Head to Head Review

Zolmax Onconova Therapeutics (NASDAQ:ONTX Get Free Report) and FutureWorld (OTCMKTS:FWDG Get Free Report) are both medical companies, but which is the better business? We will contrast the...\n more…

Critical Analysis: Onconova Therapeutics (NASDAQ:ONTX) and FutureWorld (OTCMKTS:FWDG)

Ticker Report FutureWorld (OTCMKTS:FWDG Get Free Report) and Onconova Therapeutics (NASDAQ:ONTX Get Free Report) are both medical companies, but which is the superior stock? We will contrast the...\n more…

Onconova Therapeutics (NASDAQ:ONTX) Coverage Initiated at StockNews.com

Ticker Report Research analysts at StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX Get Free Report) in a note issued to investors on Monday. The brokerage set a...\n more…

Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

Ticker Report StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX Free Report) in a research report report published on Sunday morning. The firm issued a sell rating on the...\n more…